<DOC>
	<DOCNO>NCT02217891</DOCNO>
	<brief_summary>The propose study , IFACT - Incidental Findings Advanced Cancer Therapy , address research gap examine MSK patient ' attitude , preference , information need regard incidental finding arise tumor genomic profiling .</brief_summary>
	<brief_title>IFACT : Incidental Findings Advanced Cancer Therapy</brief_title>
	<detailed_description>Part 1 , investigator recruit 40 participant already enrol exist MSK IRB protocol # 12-245 ( PI : David Hyman , MD ) include male female patient diagnose late-stage breast , colorectal , bladder , lung cancer ( common cancer study population ) . Part 2 , investigator recruit 20 participant actually receive incidental germline finding MSK IRB protocol # 12-245 Consent Part C order cognitively test novel survey item knowledge perceive utility incidental finding ( note content item derive data collect Part 1 )</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<criteria>Part 1 : Patient enrol MSK protocol # 12245 Living patient age 18 old Patient diagnose breast cancer , colorectal cancer , bladder cancer , lung cancer Patient reside New York metroarea Part 2 : Living patient age 18 older Consented Part C IRB # 12245 receive result regardless thereir pathogenic variant Patient diagnose cancer type approve IRB # 12245 Part C ( currently breast cancer , gynecological cancer , prostate cancer , GU nonprostate cancer ) breast cancer , colorectal cancer , bladder cancer , lung cancer Patient reside New York metroarea Exclusion Criteria Part 1 2 : NonEnglish speaker resource conduct translate interview language . Patient unwilling unable provide inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>